ZNF287

Across TCGA pan-cancer cohorts, ZNF287 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated ZNF287 data layer compared with 21 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher ZNF287 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF287 expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.

HNSC, BLCA, and UCEC are the cancer types where ZNF287 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	II,III,IV	0.002	0.757	<.001	36	view →
BLCA	OS	Median	III,IV	0.167	0.656	<.001	30	view →
UCEC	DFS	Median	All	0.942	0.616	.010	30	view →
READ	OS	Median	II,III,IV	0.054	0.934	<.001	24	view →
SKCM	OS	Median	II,III,IV	1.000	0.833	.025	4	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

ZNF287–HNSC (OS)

Open the HNSC breakdown →